Zhongchao Inc. (ZCMD)
$1.38+6.15%Close
BUYCRISIS · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $143,777
- Beta
- -0.01
- P/E (TTM)
- -0.01
- Short % float
- 427.16%
- Days to cover
- 1.0
- SI change
- +3.4%
- 1W
- -19.30%
- 1M
- -6.12%
- vs SPY 1W
- -18.32%
- vs SPY 1M
- -7.99%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS & VALIDATION
[SCORES & PROFILE]
- FUND
- 7
- VALUE
- 17
- GROWTH
- 36
- GARP
- 4
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-19.5%
REV YoY-
ROE-32.4%
EPS YoY-
ROA-26.0%
GROSS44
OP-54
NET-55
[VALUATION]
P/E TTM-0.01
P/E FWD-
SECTOR PE20.48
INDUSTRY PE24.48
P/B0.00
P/FCF-
EV/EBITDA1.48
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.14
ALTMAN Z-
CURR RATIO11.11
ND/EBITDA-
BETA-0.01
[BEST COMBO]VALIDATED · V5
ENTER · HOLD · EXIT · WAITOne next-open action from five signal families, published only when the held-out edge survives 20 bps costs.
Today's action with its out-of-fold profit factor, trade count and family votes.
[WHITE ARROW]FULL HISTORY
BUY
Directional consensus stays BUY or SELL until the model reverses; trades fill next session open.
PROFIT FACTOR0.2
TRADES31
[REGIME]FULL HISTORY
CRISIS
BULL or RECOVERY stays invested; BEAR or CRISIS exits at the next session open.
Profit factor and trade count for holding this symbol only in BULL or RECOVERY.
[EXHAUSTION]NOW
Whether buyers or sellers are stretched today, the latest release and its strength.
Company news
FAQ
- What is LOPJLB’s current signal on ZCMD?
- LOPJLB’s latest quantitative signal on Zhongchao Inc. (ZCMD) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is ZCMD in?
- Zhongchao Inc. (ZCMD) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Zhongchao Inc. (ZCMD) do?
- Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and …